| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 09/16/2010 | US20100234467 Methods for improving bioavailability of a renin inhibitor |
| 09/16/2010 | CA2755117A1 Substituted fused pyrimidine compounds |
| 09/16/2010 | CA2754890A1 Novel bicyclic heterocycles |
| 09/15/2010 | EP2228375A1 New xanthin derivatives, their production and utilisation as medicine |
| 09/15/2010 | EP2066669B1 Adenosine derivatives as a2a receptor agonists |
| 09/15/2010 | EP1758596B9 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof |
| 09/15/2010 | CN101835779A Purine derivatives useful as PI3 kinase inhibitors |
| 09/15/2010 | CN101835752A Heterocyclic amides useful for the treatment of cancer and psoriasis |
| 09/15/2010 | CN101830856A Entecavir intermediates and preparation method thereof |
| 09/15/2010 | CN101230065B Method for producing 9-[2(hydroxyl)propyl] adenine |
| 09/14/2010 | US7795427 Administering adenosine A1 receptor antagonist 1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine(CVT-124) for modulating osteoclastogenesis and for treating bone diseases characterized by bone loss or a decrease in bone mass or density |
| 09/14/2010 | US7795269 3-Ethyl-1-propyl-8-{1-[(3-trifluoromethylphenyl)methyl]pyrazol-4-yl}-1,3,7-trihydropurine-2,6-dione; antiasthmatic and antidiarrhea agents |
| 09/10/2010 | WO2010102212A2 Neurotrophin mimetics and uses thereof |
| 09/10/2010 | CA2754570A1 Neurotrophin mimetics and uses thereof |
| 09/09/2010 | US20100228015 Prodrug derivatives of acids using alcohols with homotopic hydroxy groups and methods for their preparation and use |
| 09/09/2010 | US20100227860 Disalt inhibitors of il-12 production |
| 09/08/2010 | CN101827949A Nucleobase characterisation |
| 09/08/2010 | CN101827847A Purine derivatives as adenosine al receptor ligands |
| 09/08/2010 | CN101827846A Valomaciclovir polymorphs |
| 09/08/2010 | CN101822676A Methods of treating patients suffering from movement disorders |
| 09/07/2010 | US7790884 2-Chloro-N-(4-chloro-2-fluorophenyl)-6,7-dimethoxyquinazoline-4-amine hydrochloride; chemokine receptor modulators; inflammatory diseases such as rheumatism, psoriasis, atopic dermatitis and asthma, allergic diseases, autoimmune diseases |
| 09/07/2010 | US7790735 Methanocarba cycloalkyl nucleoside analogues |
| 09/07/2010 | US7790730 1-((3-(4-chlorophenyl)isoxazol-5-yl)methyl)-8-(2,3-difluorophenyl)-1H-purine, used treat or prevent viral infections such as hepatitis C virus (HCV) |
| 09/07/2010 | US7790713 Inhibitors of interleukin-1β converting enzyme |
| 09/07/2010 | US7790703 New phosphonate ester derivatives of purine or pyrimidine antivirals; side effect reduction, less toxic, bioavailability |
| 09/02/2010 | US20100222300 A2B Adenosine Receptor Antagonists |
| 09/01/2010 | EP2223922A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 09/01/2010 | EP2222676A2 A1 adenosine receptor antagonists |
| 09/01/2010 | EP2222639A1 Biaryl pde4 inhibitors for treating pulmonary and cardiovascular disorders |
| 09/01/2010 | EP2222638A2 Biaryl pde4 inhibitors for treating inflammation |
| 09/01/2010 | EP1883639B1 Preparation of famciclovir and other purine derivatives |
| 09/01/2010 | CN101820881A Fused heteroaryl pyridyl and phenyl benzenesuflonamides as ccr2 modulators for the treament of inflammation |
| 09/01/2010 | CN101817849A An improved method for extracting cocoa procyanidins |
| 09/01/2010 | CN101817833A DPP-IV inhibitor |
| 09/01/2010 | CN101817822A Method for industrially preparing 6-purinethol |
| 08/31/2010 | US7786302 Producing valacyclovir hydrochloride in crystal form VIII by dissolving in dimethyl formamide at a temperature of 20-25 degrees C.; cooling the solution to 0-5 degrees C. and precipitating adding ethyl acetate, isolating, and, optionally, drying the hydrochloride VIII; solubility; bioavailability |
| 08/31/2010 | US7786301 Process for preparing xanthine phosphodiesterase V inhibitors and precursors thereof |
| 08/31/2010 | US7786300 Treating the siloxane dimer of entecavir using a halogenatedmpresence of pyridine and anethane suffonic acid and, optionally, methanesulfonic acid in the presence of pyridine and and an amine;carbon-silicon oxidation using trifluoromethane sulfonic acid andN-methylaniline |
| 08/31/2010 | US7785904 Chemiluminescence; quantitative analysis of macromolecules; complexing sample to acridinium compound, labels for improving sensitivity of immunoassays, 2',6'-dimethyl-4'-N-succinimidyloxycaproyl-amidocarbonylphenyl-N10-2,7-tris[O-methoxyhexa(ethylene) glycol-sulfonamidylpropyl]-acridinium-9-carboxylate |
| 08/31/2010 | US7785839 Methods to manufacture 1,3-dioxolane nucleosides |
| 08/26/2010 | WO2010096115A1 Compounds, compositions and methods for control of hepatitis c viral infections |
| 08/26/2010 | US20100216991 Synthesis of spongosine |
| 08/26/2010 | US20100216822 Nucleotide Analogue Prodrug and the Preparation Thereof |
| 08/26/2010 | US20100216820 Thienopyrimidiones for treatment of inflammatory disorders and cancers |
| 08/25/2010 | EP2221307A1 Purine derivatives as adenosine A1 receptor agonists and methods of use thereof |
| 08/25/2010 | EP2219448A1 Therapeutic compounds and their use in treating diseases and disorders |
| 08/24/2010 | US7781432 analgesic. especially acute, chronic and/or neuropathic pain; epilepsy and other CNS-related disorders as well as for neuroprotection or cardioprotection; 9-benzyl-8-(cyclopentylamine)-6-(4-nitrobenzyl-mercaptopurine |
| 08/19/2010 | WO2010093436A2 Toll-like receptor modulators and treatment of diseases |
| 08/19/2010 | US20100210840 Stereoselective process for preparing purine dioxolane nucleoside derivatives |
| 08/19/2010 | US20100210669 Crystalline form of entecavir, its preparation and the pharmaceutical composition and uses thereof |
| 08/19/2010 | US20100210598 Toll-like receptor modulators and treatment of diseases |
| 08/19/2010 | CA2752074A1 Toll-like receptor modulators and treatment of diseases |
| 08/18/2010 | EP1709049B1 Bicyclic imidazole compounds, the production thereof and their use as medicaments |
| 08/18/2010 | CN101805380A Method for preparing (3S, 5S)-2, 3-dihydroxyl-5-hydroxymethyl tetrahydrofuran triacetate |
| 08/18/2010 | CN101805339A Entecavir compound prepared in novel method |
| 08/17/2010 | CA2481535C Use of ep4 receptor ligands in the treatment of il-6 involved diseases |
| 08/17/2010 | CA2370412C Pharmaceutical compounds |
| 08/12/2010 | WO2010090491A2 Novel salts of adefovir dipivoxil and preparation method thereof |
| 08/12/2010 | US20100204463 Preparation Of Synthetic Nucleosides via Pi-Allyl Transition Metal Complex Formation |
| 08/12/2010 | US20100204307 Compositions And Methods For Inhibiting Expression Of The HAMP Gene |
| 08/12/2010 | US20100204250 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions |
| 08/12/2010 | US20100204248 Medicaments and methods for inhibition of non-ocular scarring |
| 08/12/2010 | US20100204187 Purine Derivatives |
| 08/12/2010 | US20100203650 Biomolecule binding ligands |
| 08/11/2010 | EP2215090A1 Purine derivatives useful as pi3 kinase inhibitors |
| 08/11/2010 | CN101801970A Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient |
| 08/11/2010 | CN101801382A Stereoselective process for preparing purine dioxolane nucleoside derivatives |
| 08/11/2010 | CN101798355A Method for integrated separation and extraction of tea polysaccharide, theanine, polyphenol and caffeine |
| 08/11/2010 | CN101148449B Salification method for 2-(6-quinolineamino)-6-cyclopropylamino-9H-purine |
| 08/10/2010 | US7772241 fused pyrido[3'.2':4.5]pyrrolo[1.2-c]pyrimidine's used for treating cancer in mammals |
| 08/10/2010 | US7772226 such as 3-(2-Butynyl)-2-(piperazin-1-yl)-3,5-dihydroimidazo[4,5-d]pyridazin-4-one trifluoroacetate, used as dipeptidyl peptidase-IV (DPPIV) inhibitors for the treatment of obesity and diabetes |
| 08/10/2010 | US7772207 Combination of a CDK inhibitor and CS-682 or a metabolite thereof |
| 08/05/2010 | WO2010085924A2 Substituted 6-(2-aminobenzylamino)purine derivatives, their use as medicaments and preparations containing these compounds |
| 08/05/2010 | US20100197914 Purine Derivatives as Adenosine Al Receptor Ligands |
| 08/05/2010 | US20100197913 Non-nucleotide composition for inhibiting platelet aggregation |
| 08/05/2010 | US20100197688 Epha4 rtk inhibitors for treatment of neurological and neurodegenerative disorders and cancer |
| 08/04/2010 | CN101148448B Method for preparing N2-quinoline substituted purine derivative |
| 08/04/2010 | CN101130542B Synthesis method of antiviral nucleoside analogue |
| 08/04/2010 | CN101044141B Purine derivatives for use as adenosin A-2A receptor agonists |
| 08/03/2010 | US7767687 Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as RAF kinase inhibitors |
| 08/03/2010 | US7767685 8-pyrazolo-xanthine derivatives such as 2-[3-(2,6-Dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-5-methyl-pyrazol-1-yl]-N-phenyl-acetamide, used for treating asthma, rhinitis, dermatitis, diabetes, tumors, reperfusion injuries, inflammatory bowel disease, autoimmune diseases and vison defects |
| 08/03/2010 | US7767670 Substituted 3-carboxamido isoxazoles as kinase modulators |
| 08/03/2010 | CA2591818C Process for the preparation of optically active aminoalcohols |
| 08/03/2010 | CA2523081C Macrolide-conjugates with anti-inflammatory activity |
| 07/29/2010 | US20100190806 Substituted 6-anilinopurine derivatives as inhibitors of cytokinin oxidase/dehydrogenase and preparations containing these derivatives |
| 07/29/2010 | US20100190788 Amide derivatives as kinase inhitors |
| 07/29/2010 | US20100190787 Modulators of Mitotic Kinases |
| 07/29/2010 | US20100190784 Organic Compounds |
| 07/29/2010 | US20100190746 Quinazolinones as potassium channel modulators |
| 07/28/2010 | EP2209786A1 Pyrimidine substituted purine derivatives |
| 07/28/2010 | EP2209785A1 2-morpholinylpurines as inhibitors of pi3k |
| 07/28/2010 | EP1633746B1 New indole derivatives as factor xa inhibitors |
| 07/28/2010 | CN101787027A Preparation method of high-purity carbamazepine (CBZ)-valaciclovir |
| 07/28/2010 | CN101787026A Amorphous entecavir p-toluenesulfonate salt and preparation method and medicament application thereof |
| 07/28/2010 | CN101130552B Process for preparing the antiviral agent [1s-(1alpha, 3alpha, 4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6h-purin-6-one |
| 07/27/2010 | US7763625 administering adenosine A2 receptor antagonists comprising xanthine derivatives such as 8-[(E)-2-(3,4-dimethoxyphenyl)ethenyl]-1,3-diethyl-7-methylpurine-2,6-dione, for the treatment of headaches |
| 07/22/2010 | WO2010056907A3 Heterocyclic compounds that induce pancreatic beta-cell expansion |
| 07/22/2010 | US20100183564 Compounds that expand hematopoietic stem cells |
| 07/21/2010 | EP2207779A1 Method of synthesis of morpholino oligomers |
| 07/21/2010 | EP1636216B1 BENZIMIDAZOLE-DERIVATIVES AS FACTOR Xa INHIBITORS |